Pharmacokinetics of Ampicillin/Sulbactam in Critically Ill Patients with Acute Kidney Injury undergoing Extended Dialysis

BACKGROUND AND OBJECTIVES: The fixed antibacterial combination of ampicillin and sulbactam is frequently used for various infections. Intact kidneys eliminate approximately 71% of ampicillin and 78% of sulbactam. Patients on thrice-weekly low-flux hemodialysis exhibit an ampicillin t(1/2) of 2.3 hou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lorenzen, Johan M., Broll, Michael, Kaever, Volkhard, Burhenne, Heike, Hafer, Carsten, Clajus, Christian, Knitsch, Wolfgang, Burkhardt, Olaf, Kielstein, Jan T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2012
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3302675/
https://ncbi.nlm.nih.gov/pubmed/22223613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.05690611
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak